|
 |
DesonideThis page contains recent news articles, when available, and an overview of Desonide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Desonide (when available) Budesonide is a synthetic corticosteroid indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon. Budesonide is used in Crohn's disease to decrease the symptoms and inflammation associated with the disease, especially at times of flare up. Budesonide has a high topical glucocorticosteroid (GCS) activity and a substantial first pass elimination. The formulation contains granules which are coated to protect dissolution in gastric juice, but which dissolve at pH >5.5, ie, normally when the granules reach the duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the release of the drug into the intestinal lumen in a time-dependent manner. For the treatment of mild to moderate active Crohn's disease. Mechanism Of Action: The exact mechanism of action of budesonide in the treatment of Crohn's disease is not fully understood. However, being a glucocorticosteroid, budesonide has a high local anti-inflammatory effect. News Articles on Budesonide InfoMedics Study Assists Physicians in Evaluating New Treatment ... - Apr 3, 2009 InfoMedics, Inc., the patient feedback company, recently presented a poster detailing patients' experiences with desonide hydrogel for the treatment of mild PR-USA.net (press release) Desonide Hydrogel for Dermatitis Effective, Results in High ... - Mar 10, 2009 By Jill Stein SAN FRANCISCO -- March 10, 2009 -- Use of desonide hydrogel in patients with mild to moderate atopic dermatitis resulted in significant DG News Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic ... - Mar 5, 2009 ...for this age group to treat atopic dermatitis and eczema include fluocinolone acetonide, topical oil 0.01%, desonide gel 0.05% and desonide foam 0.05%. PR Newswire (press release) Several atopic dermatitis therapies under investigation, but mixed ... - Mar 9, 2009 Topical steroids, including fluocinolone acetonide topical oil 0.01% and desonide foam, remain the mainstay of treatment for atopic dermatitis. Pediatric SuperSite SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne - Jan 14, 2009 SkinMedica's pharmaceutical products include Desonate(R) (desonide) Gel 0.05% for the treatment of mild to moderate atopic dermatitis; PR Newswire (press release), SkinMedica Hosts Aesthetics Division National Sales Meeting - Oct 29, 2008 SkinMedica's pharmaceutical products include Desonate(R) (desonide) Gel 0.05% for the treatment of mild to moderate atopic dermatitis; SYS-CON Media, SkinMedica Launches TNS Essential Serum(TM) - Nov 6, 2008 SkinMedica's Desonate(R) (desonide) Gel 0.05% is indicated for the treatment of mild-to-moderate atopic dermatitis; EpiQuin(R) Micro (4% hydroquinone) cream Earthtimes (press release), Stiefel Laboratories Completes Acquisition of Barrier Therapeutics - 07 Aug 2008 Verdeso(R) (desonide) Foam, 0.05%; Brevoxyl(R)-4 Creamy Wash (benzoyl peroxide 4%) and Brevoxyl(R)-8 Creamy Wash (benzoyl peroxide 8%) packaged in the MarketWatch Stiefel Completes Add-On - 07 Aug 2008 Soriatane® (acitretin) Capsules available in the Soriatane® CK CONVENIENCE KIT; Verdeso® (desonide) Foam, 0.05%; Brevoxyl®-4 Creamy Wash (benzoyl Private Equity Hub, Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott ... - Jul 29, 2008 Verdeso(R) (desonide) Foam, 0.05%; Brevoxyl(R)-4 Creamy Wash (benzoyl peroxide 4%) and Brevoxyl(R)-8 Creamy Wash (benzoyl peroxide 8%) packaged in the MarketWatch Stiefel Laboratories, Inc. Commences Tender Offer to Acquire ... - Jul 8, 2008 Verdeso(R) (desonide) Foam, 0.05%; Brevoxyl(R)-4 Creamy Wash (benzoyl peroxide 4%) and Brevoxyl(R)-8 Creamy Wash (benzoyl peroxide 8%) packaged in the FOXBusiness Stiefel Laboratories, Inc. Successfully Completes Tender Offer for ... - Aug 5, 2008 Verdeso(R) (desonide) Foam, 0.05%; Brevoxyl(R)-4 Creamy Wash (benzoyl peroxide 4%) and Brevoxyl(R)-8 Creamy Wash (benzoyl peroxide 8%) packaged in the Trading Markets (press release), SkinMedica(R) Launches New Informational Web Site - Jun 24, 2008 SkinMedica's Desonate(R) (desonide) Gel 0.05% is indicated for the treatment of mild-to-moderate atopic dermatitis; EpiQuin(R) Micro (4% hydroquinone) cream Earthtimes (press release), Stiefel Buying Barrier Therapeutics - Jun 24, 2008 Soriatane® (acitretin) Capsules available in the Soriatane® CK CONVENIENCE KIT; Verdeso® (desonide) Foam, 0.05%; Brevoxyl®-4 Creamy Wash (benzoyl Private Equity Hub, OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday ... - Jun 23, 2008 Soriatane (acitretin) Capsules available in the Soriatane CK CONVENIENCE KIT; Verdeso (desonide) Foam, 0.05%; Brevoxyl -4 Creamy Wash (benzoyl peroxide Trading Markets (press release), Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development - May 6, 2008 Verdeso(R) (desonide) Foam, 0.05%; Brevoxyl(R)-4 Creamy Wash (benzoyl peroxide 4%) and Brevoxyl(R)-8 Creamy Wash (benzoyl peroxide 8%) packaged in the Trading Markets (press release), International Diabetes Federation Grant Supports Diabetes Self ... - May 7, 2008 Verdeso(R) (desonide) Foam, 0.05%; Brevoxyl(R)-4 Creamy Wash (benzoyl peroxide 4%) and Brevoxyl(R)-8 Creamy Wash (benzoyl peroxide 8%) packaged in the Trading Markets (press release), Stiefel Laboratories Appoints First Chief Scientific Officer - Apr 7, 2008 Verdeso(TM) (desonide) Foam, 0.05%; Brevoxyl(R)-4 Creamy Wash (benzoyl peroxide 4%) and Brevoxyl(R)-8 Creamy Wash (benzoyl peroxide 8%) packaged in the æ–°å?Žç¾Žé€š(æ–°é—»å?‘布), SkinMedica Appoints Mary Fisher Chief Executive Officer - Apr 3, 2008 SkinMedica’s Desonate® (desonide) Gel 0.05% is indicated for the treatment of mild to moderate atopic dermatitis; EpiQuin® Micro (4% hydroquinone) cream is Business Wire (press release), Eczema Medication - 11 Mar 2008 Weak steroids like hydrocorticone or desonide are used for mils and moderate eczema. In sever cases high potency steroids like clobetasol propionate are Los Angeles Chronicle, DUSA Announces Stiefel's Receipt of Pricing Approval of Levulan ... - Mar 6, 2008 Verdeso(TM) (desonide) Foam, 0.05%; Brevoxyl® Creamy Wash (benzoyl peroxide, 4% or 8%) packaged in the convenient new Brevoxyl Acne Wash Kit; Oilatum®; CNNMoney.com Businessnetwire.us: NASDAQ Stock News You Can Use: SMOD, DUSA, DAIO - Mar 6, 2008 Olux-ETM (clobetasol propionate) Foam, 0.05%; Soriatane (acitretin) capsules; VerdesoTM (desonide) Foam, 0.05%; Brevoxyl Creamy Wash (benzoyl peroxide, Trading Markets (press release), Stiefel Laboratories, Inc. Appoints New President - Feb 29, 2008 0.05%) Foam; Olux-E(TM) (clobetasol propionate, 0.05%) Foam; Soriatane(R) (acitretin) CK CONVENIENCE KIT(TM); Verdeso(TM) (desonide, 0.05%) Foam; Biloxi Sun Herald, Brand Names/Synonyms: Desonide is also known by the following brand names and/or synonyms: Bidien; Budeson; Budesonide; Budesonide, Pharma; BudesonideÊ; Cortivent; Desonide; Desowen; Entocort; Entocort Ec; Micronyl; Preferid; Pulmicort; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Turbuhaler; Rhinocort; Rhinocort Aqua; Rhinocort Turbuhaler; Spirocort; Tridesilon Drug Category: Desonide is categorized under the following by the FDA: Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06; ATC:D07AC09; ATC:R01AD05; ATC:R03BA02 Dosage Forms: CAPSULE (SUSTAINED-RELEASE); METERED-DOSE (AEROSOL); SUSPENSION Absorption: Complete Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: Not Available |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
